Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 3/1998

01-03-1998 | Adis Drug Evaluation

Brimonidine

A Review of its Pharmacological Properties and Clinical Potential in the Management of Open-Angle Glaucoma and Ocular Hypertension

Authors: Julie C. Adkins, Julia A. Balfour

Published in: Drugs & Aging | Issue 3/1998

Login to get access
Metadata
Title
Brimonidine
A Review of its Pharmacological Properties and Clinical Potential in the Management of Open-Angle Glaucoma and Ocular Hypertension
Authors
Julie C. Adkins
Julia A. Balfour
Publication date
01-03-1998
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 3/1998
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-199812030-00005

Other articles of this Issue 3/1998

Drugs & Aging 3/1998 Go to the issue

Leading Article

Should Antioxidant Vitamins be Routinely Recommended for Older People?

Adis New Drug Profile

Propionyl-L-Carnitine

Review Article

Assessment and Treatment of Bipolar Disorder in the Elderly

Review Article

Calcium Sensitising Agents in Heart Failure

Adis New Drug Profile

Propionyl-L-Carnitine

Adis New Drug Profile

Propionyl-L-Carnitine
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits